Re near term drivers, @pfeifer1982 previously pointed out the OA trial will see a patient being treated with iPS cells in AU for the very first time.
Also in the recent investor presentation Ross said cells for this trial are manufactured, accounted for and ready to go.
Let's hope Professor Hunter on (or close to) schedule with the soon to start trial.
Note CYP keeps commercial rights for this government funded OA phase 2 trial, market size estimated at USD11.5bn pa revenue (AUD17+bn pa). Hopefully we get the results going the same way as our pre-clinical results. A lot more excited about this one than the planned GvHD phase 2 which seems to get most attention on this site.
Mcnamm, page-24
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $33.42M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $14.31K | 75.89K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17870 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 18714 | 1 |
View Market Depth
| Last trade - 14.43pm 09/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |